Analyze Diet
American journal of veterinary research2010; 71(11); 1371-1376; doi: 10.2460/ajvr.71.11.1371

Pharmacokinetics of gallium maltolate after intragastric administration in adult horses.

Abstract: To determine the pharmacokinetics of gallium maltolate (GaM) after intragastric administration in adult horses. Methods: 6 adult horses. Methods: Feed was withheld for 12 hours prior to intragastric administration of GaM (20 mg/kg). A single dose of GaM was administered to each horse via a nasogastric tube (time 0). Blood samples were collected at various time points from 0 to 120 hours. Serum was used to determine gallium concentrations by use of inductively coupled plasma-mass spectroscopy. Noncompartmental and compartmental analyses of serum gallium concentrations were performed. Pharmacokinetic models were selected on the basis of the Akaike information criterion and visual analysis of plots of residuals. Results: Serum concentration data for 1 horse were such that this horse was considered an outlier and excluded from noncompartmental and compartmental analyses. Noncompartmental analysis was used to determine individual pharmacokinetic parameters. A 1-compartment model with first-order input and output and lag time was selected as the best-fit model for the data and used to determine mean ± SD values for maximum observed serum concentration (0.28 ± 0.09 μg/mL), time of maximum concentration (3.09 ± 0.43 hours), time to the first measurable concentration (0.26 ± 0.11 hours), apparent elimination half-life (48.82 ± 5.63 hours), area under the time-concentration curve (20.68 ± 757 h•μg/mL), and apparent volume of distribution (73,493 ± 18,899 mL/kg). Conclusions: Further studies are necessary to determine the bioavailability of GaM after intragastric administration in adult horses.
Publication Date: 2010-11-03 PubMed ID: 21034329DOI: 10.2460/ajvr.71.11.1371Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research analyses how gallium maltolate, a therapeutic agent, behaves in the body of horses after being administered orally. The study evaluates the drug absorption, distribution, and elimination patterns in horses to understand its effectiveness and dosing.

Research Methodology

  • The study was conducted on six adult horses.
  • Food was withheld from the horses 12 hours before administering gallium maltolate, a method known as intragastric administration.
  • The drug was delivered via a tube inserted through the nose and down into the horse’s stomach (nasogastric tube).
  • Blood samples were collected over a period of 120 hours at different time intervals to monitor and measure the concentration of gallium in the system.
  • These concentrations were then used in both noncompartmental and compartmental analyses to understand the pharmacokinetics—the body’s impact on the drug—of gallium maltolate.
  • The pharmacokinetic models were selected based on the Akaike information criterion and visual analysis of the data set plots.

Research Findings

  • One horse’s serum concentration data considerably deviated from the others and was considered an outlier. This horse’s data was therefore excluded from the analysis.
  • Based on the data collected, the researchers settled on a one-compartment model with a first-order input and output to best describe the drug’s pharmacokinetics.
  • In the body of horses, it was established that maximum observed serum concentration was 0.28 ± 0.09 μg/mL with the time of maximum concentration being 3.09 ± 0.43 hours post-administration.
  • The first measureable concentration occurred 0.26 ± 0.11 hours after the drug was administered.
  • The apparent elimination half-life—the time it takes for the drug concentration to reduce by half—was 48.82 ± 5.63 hours.
  • The area under the time-concentration curve, used to represent total body exposure to the drug, was found to be 20.68 ± 757 h•μg/mL.
  • The apparent volume of distribution, indicating the theoretical volume that would contain the total drug administered at the same concentration that is measured in the blood, was calculated as 73,493 ± 18,899 mL/kg.

Conclusions and Future Work

  • Despite obtaining insightful findings, the study acknowledges the need for further research to conclusively determine the bioavailability—the rate and extent to which the active ingredient or active moiety is absorbed and becomes available at the site of action—of gallium maltolate after intragastric administration in adult horses.

Cite This Article

APA
Arnold C, Chaffin MK, Cohen N, Fajt VR, Taylor RJ, Bernstein LR. (2010). Pharmacokinetics of gallium maltolate after intragastric administration in adult horses. Am J Vet Res, 71(11), 1371-1376. https://doi.org/10.2460/ajvr.71.11.1371

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 71
Issue: 11
Pages: 1371-1376

Researcher Affiliations

Arnold, Carolyn
  • Department of Large Animal Clinical Sciences, Texas A&M University, College Station, 77843, USA. Carnold@cvm.tamu.edu
Chaffin, M Keith
    Cohen, Noah
      Fajt, Virginia R
        Taylor, Robert J
          Bernstein, Lawrence R

            MeSH Terms

            • Animals
            • Bone Diseases / drug therapy
            • Bone Diseases / prevention & control
            • Bone Diseases / rehabilitation
            • Bone Diseases / veterinary
            • Female
            • Gallium / blood
            • Gallium / pharmacokinetics
            • Gallium / pharmacology
            • Gallium / therapeutic use
            • Horse Diseases / prevention & control
            • Horses
            • Humans
            • Injections, Intravenous / veterinary
            • Male
            • Orchiectomy / veterinary
            • Organometallic Compounds / administration & dosage
            • Organometallic Compounds / pharmacokinetics
            • Organometallic Compounds / therapeutic use
            • Pyrones / administration & dosage
            • Pyrones / pharmacokinetics
            • Pyrones / therapeutic use

            Citations

            This article has been cited 0 times.